The scope of the report includes the revenue generated by the sales of oral protein and peptide drugs. As most of the protein and peptide drugs are currently in phase I, II, and III of clinical trials and development, a market potential model has been developed for this market. In this report, the global oral proteins and peptides market is analyzed with respect to drug type, application, and geographical analysis. Based on drug type, the market is divided into linaclotide, plecanatide, calcitonin, insulin, and octreotide. The applications covered in this study include gastric & digestive disorders, bone diseases, diabetes, and hormonal disorders.

CHAPTER 1: INTRODUCTION

CHAPTER 2: EXECUTIVE SUMMARY

CHAPTER 3: MARKET OVERVIEW

CHAPTER 4: ORAL PROTEINS AND PEPTIDES MARKET, BY DRUG TYPE

CHAPTER 5: ORAL PROTEINS AND PEPTIDES MARKET, BY APPLICATION

CHAPTER 6: ORAL PROTEINS AND PEPTIDES MARKET, BY REGION

CHAPTER 7: COMPANY PROFILES